Literature DB >> 18040076

Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue.

Kara B Bowen1, Aaron P Reimers, Sarah Luman, Joseph D Kronz, William E Fyffe, Julia Thom Oxford.   

Abstract

In previous studies, collagen XI mRNA has been detected in colon cancer, but its location in human colon tissue has not been determined. The heterotrimeric collagen XI consists of three alpha chains. While it is known that collagen XI plays a regulatory role in collagen fibril formation, its function in the colon is unknown. The characterization of normal human colon tissue will allow a better understanding of the variance of collagen XI in abnormal tissues. Grossly normal and malignant human colon tissue was obtained from pathology archives. Immunohistochemical staining with a 58K Golgi marker and alpha1(XI) and alpha2(XI) antisera was used to specifically locate their presence in normal colon tissue. A comparative bright field microscopic analysis showed the presence of collagen XI in human colon. The juxtanuclear, dot-like collagen XI staining in the Golgi apparatus of goblet cells in normal tissue paralleled the staining of the 58K Golgi marker. Ultra light microscopy verified these results. Staining was also confirmed in malignant colon tissue. This study is the first to show that collagen XI is present in the Golgi apparatus of normal human colon goblet cells and localizes collagen XI in both normal and malignant tissue. Although the function of collagen XI in the colon is unknown, our immunohistochemical characterization provides the foundation for future immunohistopathology studies of the colon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040076      PMCID: PMC2324180          DOI: 10.1369/jhc.7A7310.2007

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  31 in total

1.  Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.

Authors:  T Falguières; F Mallard; C Baron; D Hanau; C Lingwood; B Goud; J Salamero; L Johannes
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

2.  Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells.

Authors:  Yan Feng; Ashutosh P Jadhav; Chiara Rodighiero; Yukako Fujinaga; Tomas Kirchhausen; Wayne I Lencer
Journal:  EMBO Rep       Date:  2004-05-21       Impact factor: 8.807

3.  Electron microscopic and cytochemical studies of rat aorta. Intracellular vesicles containing elastin- and collagen-like material.

Authors:  J Thyberg; A Hinek; J Nilsson; U Friberg
Journal:  Histochem J       Date:  1979-01

4.  Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.

Authors:  Inn-Wen Chong; Mei-Yin Chang; Huang-Chou Chang; Ya-Ping Yu; Chau-Chyun Sheu; Jong-Rung Tsai; Jen-Yu Hung; Shah-Hwa Chou; Mee-Sun Tsai; Jhi-Jhu Hwang; Shiu-Ru Lin
Journal:  Oncol Rep       Date:  2006-11       Impact factor: 3.906

5.  Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2.

Authors:  H Fischer; R Stenling; C Rubio; A Lindblom
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

6.  Structural organization of distinct domains within the non-collagenous N-terminal region of collagen type XI.

Authors:  K E Gregory; J T Oxford; Y Chen; J E Gambee; S P Gygi; R Aebersold; P J Neame; D E Mechling; H P Bächinger; N P Morris
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

Review 7.  The intracellular voyage of cholera toxin: going retro.

Authors:  Wayne I Lencer; Billy Tsai
Journal:  Trends Biochem Sci       Date:  2003-12       Impact factor: 13.807

8.  BMP-1-mediated proteolytic processing of alternatively spliced isoforms of collagen type XI.

Authors:  Ryan J Medeck; Sergio Sosa; Nicholas Morris; Julia Thom Oxford
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

9.  Interaction between amino propeptides of type XI procollagen alpha1 chains.

Authors:  Julia Thom Oxford; Joseph DeScala; Nick Morris; Kate Gregory; Ryan Medeck; Katey Irwin; Rex Oxford; Raquel Brown; Linda Mercer; Sorcha Cusack
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  COL11A1 in FAP polyps and in sporadic colorectal tumors.

Authors:  H Fischer; S Salahshor; R Stenling; J Björk; G Lindmark; L Iselius; C Rubio; A Lindblom
Journal:  BMC Cancer       Date:  2001-10-29       Impact factor: 4.430

View more
  11 in total

1.  Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

Authors:  Marleen van Oosten; Lucia Ma Crane; Joost Bart; Fijs W van Leeuwen; Gooitzen M van Dam
Journal:  Transl Oncol       Date:  2011-04-01       Impact factor: 4.243

2.  Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms.

Authors:  Ioannis K Toumpoulis; Julia Thom Oxford; Douglas B Cowan; Constantine E Anagnostopoulos; Chris K Rokkas; Themistocles P Chamogeorgakis; Dimitrios C Angouras; Richard J Shemin; Mohamad Navab; Maria Ericsson; Micheline Federman; Sidney Levitsky; James D McCully
Journal:  Ann Thorac Surg       Date:  2009-08       Impact factor: 4.330

3.  Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma.

Authors:  Bohan Zhang; Cheng Zhang; Xuetao Yang; Yue Chen; Hongqi Zhang; Jingshu Liu; Qingchen Wu
Journal:  Cancer Biol Ther       Date:  2018-02-05       Impact factor: 4.742

4.  Expression of extracellular matrix components is disrupted in the immature and adult estrogen receptor β-null mouse ovary.

Authors:  Alexandra Zalewski; Erin L Cecchini; Bonnie J Deroo
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

5.  Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens.

Authors:  Makrina Karaglani; Ioannis Toumpoulis; Nikolaos Goutas; Nikoleta Poumpouridou; Dimitrios Vlachodimitropoulos; Spyridon Vasilaros; Ioannis Rizos; Christos Kroupis
Journal:  BMC Cancer       Date:  2015-10-14       Impact factor: 4.430

6.  Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma.

Authors:  José A Galván; Jorge García-Martínez; Fernando Vázquez-Villa; Marcos García-Ocaña; Carmen García-Pravia; Primitiva Menéndez-Rodríguez; Carmen González-del Rey; Luis Barneo-Serra; Juan R de los Toyos
Journal:  BMC Cancer       Date:  2014-11-23       Impact factor: 4.430

7.  Integrated bioinformatics analysis of key genes involved in progress of colon cancer.

Authors:  Haojie Yang; Jiong Wu; Jingjing Zhang; Zhigang Yang; Wei Jin; Ying Li; Lei Jin; Lu Yin; Hua Liu; Zhenyi Wang
Journal:  Mol Genet Genomic Med       Date:  2019-02-11       Impact factor: 2.183

8.  Collagen Type XI Alpha 1 Expression in Intraductal Papillomas Predicts Malignant Recurrence.

Authors:  Javier Freire; Lucia García-Berbel; Pilar García-Berbel; Saray Pereda; Ainara Azueta; Pilar García-Arranz; Ana De Juan; Alfonso Vega; Ángela Hens; Ana Enguita; Pedro Muñoz-Cacho; Javier Gómez-Román
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

9.  Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer.

Authors:  Carmen García-Pravia; José A Galván; Natalia Gutiérrez-Corral; Lorena Solar-García; Eva García-Pérez; Marcos García-Ocaña; Jokin Del Amo-Iribarren; Primitiva Menéndez-Rodríguez; Juan García-García; Juan R de Los Toyos; Laureano Simón-Buela; Luis Barneo
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

10.  Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer.

Authors:  Chen Su; Jiabao Zhao; Xinya Hong; Sijiu Yang; Ying Jiang; Jingjing Hou
Journal:  Mol Med Rep       Date:  2019-09-10       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.